neuropathic

Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain

STAMFORD, Conn, Nov. 20 /PRNewswire/ -- Purdue Pharma L.P. and Mundipharma International Corporation Limited, today announced that they have entered into a global strategic alliance with Infinity Pharmaceuticals, Inc. to advance the research, development, and commercialization of In...

Medicinal Marijuana Eases Neuropathic Pain in HIV

Cannabis was well-tolerated, effective when added to existing meds, study finds WEDNESDAY, Aug. 6 (HealthDay News) -- Medicinal marijuana helps relieve neuropathic pain in people with HIV, says a University of California, San Diego, School of Medicine study. It included 28 HIV pati...

Newly Labeled Therapies for Neuropathic Pain, Including Drugs From Pfizer and Eli Lilly, Will Drive Growth in the Chronic Pain Drug Market

Following Recovery From Withdrawal of Two COX-2 Inhibitors, the Chronic Pain Drug Market Will Regain Momentum, According to a New Report from Decision Resources WALTHAM, Mass., March 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and adv...

Protein found that may provide relief from neuropathic pain

Neuropathic pain is caused by injury to the peripheral nerves in diseases such as HIV/AIDS, shingles, and cancer or in repetitive motion disorders and trauma, and does not respond well to conventional pain-relieving drugs. Research in rodents by scientists from the University of California, S...

UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain

U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for the use of lacosamide in the treatment of adults with diabetic neuropathic pain. ATLANTA, Nov. 29 /PRNewswire/ -- UCB announced today that the U.S. Food and Drug Administration...

Smoked cannabis proven effective in treating neuropathic pain

Smoked cannabis eased pain induced in healthy volunteers, according to a study by researchers at the University of California, San Diego (UCSD) Center for Medical Cannabis Research (CMCR.) However, the researchers found that less may be more. In the placebo controlled study of 15 subjects, a l...

Quigley Corporation Announces Final Results of Quigley Pharma's Phase IIb Study

... The ADA estimates that neuropathy occurs in up to 60-70% of diabetics, and an estimated 5 million Americans are affected by diabetic peripheral neuropathic pain. The World Health Organization estimates that more than 171 million people have diabetes worldwide, a figure that is expected to rise to 366 mill...

NeurogesX Announces Resignation of Bruce A. Peacock from Board of Directors

...rapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), pain...designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatment of neuropathic pain in non-diabetic adults, either alone or in co...

Sundia MediTech Appoints Dr. Chen Chen as Senior VP of Chemistry

...-4 receptor for eating disorders. Dr. Chen has extensive experience in CNS drug research and GPCRs as drug targets. His knowledge also includes neuropathic pain and metabolic disorders. His research interests extend to clinic and preclinic pharmacokinetics of small molecules and the relationship with thei...

Clinical Study Data Indicates that Celliant Reduces Pain

...yone suffers from some sort of ache or pain during their life." In fact, this most recent study included subjects who suffered from diabetic neuropathic pain as well as a second group of non-diabetic subjects. Both groups experienced significant pain relief. The data showing a greater reduction in pain...

neuropathic in Medical Technology

Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharma's Product Class

SAN DIEGO, July 13 /PRNewswire/ -- Research published in the June 26, 2009 edition of Proceedings of National Academy of Sciences provides further evidence for novel roles of tRNA synthetases in disease, validating the therapeutic potential for aTyr Pharma's new class of naturally occurring prot...

XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain

VALLEY COTTAGE, N.Y., June 30 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (Nasdaq: XTLB ; TASE: XTL) today announced that it has completed patient randomization into its Phase 2b study of Bicifadine -- a serotonin and norepinephrine reuptake inhibitor (SNRI) -- for the treatment of ...

New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain

Results presented at the 27th Annual Meeting of the American Pain Society (APS) SMYRNA, Ga., May 8 /PRNewswire/ -- Patients treated with lacosamide demonstrated sustained pain relief from diabetic neuropathic pain (DNP), compared to placebo-treated patients, acco...

Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain

UCB announces clinical data presented at the 60th Annual Meeting of the American Academy of Neurology (AAN) in Chicago SMYRNA, Ga., April 16 /PRNewswire/ -- UCB presented efficacy and safety results from pooled analyses of Phase II and III double-blind, randomized, placebo-controll...

Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Apr 18, 2007 - Avanir Pharmaceuticals (NASDAQ:AVNR) today announced positive top-line results from the company's Phase III clinical trial evaluating the investigational drug Zenvia(TM) (dextromethorphan hydrobromide/quinidine sulfate ("DMQ")), an NMDA antagonis...

Cephalon Presents Positive Results for Fentora in Breakthrough Pain Associated with Neuropathic Conditions

All Efficacy Measures Reached Statistical Significance FRAZER, Pa., May 01, 2007 /PRNewswire-FirstCall/ -- A Cephalon, Inc. Phase 3 clinical trial presented today at the 59th Annual Meeting of the American Academy of Neurology in Boston highlights data demonstrating that FENTORA(R) (fentan...

AVANIR Pharmaceuticals to Present Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at Second International Congress on Neuropathic Pain

ALISO VIEJO, Calif.--(BUSINESS WIRE)--May 8, 2007 - AVANIR Pharmaceuticals (NASDAQ:AVNR) today announced Phase III data on the efficacy, safety and improvements in patient-centered outcomes in patients with diabetic peripheral neuropathic (DPN) pain treated with the investigational drug Zenvia(TM) ...

NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)

SAN CARLOS, Calif., June 07, 2007 /PRNewswire-FirstCall/ -- NeurogesX, Inc. announced today the presentation of clinical data from a positive Phase 3 trial in postherpetic neuralgia (PHN). Misha-Miroslav Backonja, M.D., Professor of Neurology at University of Wisconsin in Madison and lead academic...

AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic Peripheral Neuropathic Pain at International Congress on Neuropathic Pain

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Jun 8, 2007 - AVANIR Pharmaceuticals (NASDAQ:AVNR) today announced the presentation of Phase III data, including efficacy, safety and improvements in patient-centered outcomes in patients with diabetic peripheral neuropathic (DPN) pain treated with the investig...

Expert Opinion Highlights Avigen's AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal

Focus On AV411's Unique Mechanism of Action and Broad Potential for the Treatment of Neurological Conditions ALAMEDA, Calif., June 26, 2007 (PRIME NEWSWIRE) -- Avigen, Inc. (Nasdaq:AVGN), a biopharmaceutical company innovating therapeutics for the treatment of neurological conditions, announce...

More>>

neuropathic in Medical Products

PneumaticWalker™ Diabetic System

Description:... Pressure Gauge is included with each System to measure individual aircell compression. This precise measuring ensures regulated aircell inflation for neuropathic patients. The PneumaticWalker Diabetic System is an ideal alternative to total contact casting. Unlike casting which requires costly and time consumi...
Company:Aircast

neuropathic in Medical Dictionary

Trigeminal neuralgia

...wn as ... suggest that ATN may be an early development of Trigeminal Neuralgia . ... Trigeminal neuralgia (TN) or tic douloureux is a neuropathic disorder of one or both of the facial trigeminal nerves. It causes episodes of intense pain in any or all of the following: the ear, eye, lips, no...

Tic douloureux

... Trigeminal neuralgia (TN) or tic douloureux is a neuropathic disorder of one or both of the facial trigeminal nerves. It causes episodes of intense pain in any or all of the following: the ear, eye, lips, nose...

Syringomyelia

...ngomyelia is not the name you expected. Please check the synonyms listing to find the alternate name ... Syringomyelia causes a wide variety of neuropathic symptoms due to damage of the ... Physicians now use magnetic resonance imaging (MRI) to diagnose syringomyelia . ... ...

Reflex Sympathetic Dystrophy

...ondition of burning pain, ... Often, an injury can cause reflex sympathetic dystrophy . ... Reflex sympathetic dystrophy is a type of neuropathic pain. ... With reflex sympathetic dystrophy , swelling and sweating, changes in blood flow ... The detection of reflex sympathetic d...

Prevalence

... incidence, which ... The formula for calculating prevalence is: ... Abstract and Introduction: A large proportion of the diabetic population is neuropathic and, therefore, at risk of foot ulceration. ...

Pain Management

... Care doctors are also specialists in pain management . ... Learn about pain management and pain treatment options for nociceptive, neuropathic pain (for example fibromyalgia, irritable bowel syndrome), and chronic pain . ... better to talk to about dealing with back pain than the...

Neuralgia

... Neuralgia or neuropathic pain can be defined most simply as non-nociceptive pain, or in other word...re or function.... Trigeminal neuralgia (TN) or tic douloureux is a neuropathic disorder of one or both of the facial trigeminal nerves. It causes episodes...

Diabetic neuropathy

... Diabetic neuropathies are neuropathic disorders that are associated with diabetes mellitus. These conditions are thought to result from diabetic microvascular injury involving small ...

neuropathic in Biological News

Scientists use gene transfer technology and common virus to block neuropathic pain

Remember how it felt the last time you burned your finger on a hot stove? Imagine what it's like to have that burning pain in your hands or feet all the time and know there's virtually nothing you can do about it. It's called neuropathic pain, and it's a common complication of many diseases and m...

Scientists use gene transfer technology and common virus to block neuropathic pain in animals

Remember how it felt the last time you burned your finger on a hot stove? Imagine what it's like to have that burning pain in your hands or feet all the time and know there's virtually nothing you can do about it. David Fink, M.D.It's called neuropathic pain, and it's a common complication of ma...

Neuropathic pain: The sea provides a new hope of relief

... scientists to develop a new set of treatments for neuropathic pain chronic pain that sometimes follows damage t...used for urinary incontinence, has given relief in neuropathic pain; similarly, two drugs designed for treating e... painkillers are urgently needed for patients with neuropathic pain," says Dr Zhi-Hong Wen, who played a key role...

Yale team identifies key to potential new treatment for allergy-induced asthma

... have discovered that a protein may be a trigger of allergy-induced asthma in mice. They also demonstrated how a drug known to reduce inflammatory and neuropathic pain may also inhibit asthma symptoms in mice. Their paper is published in the May 18-22 online Early Edition of the Proceedings of the National Acad...

New approach discovered to lowering triglycerides

... ability to reduce mitochondrial decay in cells and perhaps slow the process of aging. And it's been used in Europe for decades as a treatment for the neuropathic complications of diabetes. "Lipoic acid is known to influence glucose uptake, and bring down blood glucose by increasing its transport into skeleta...

Medicare coding for maggots and maggot therapy

...ed fly larvae for treating chronic wounds. Medical Maggots brand of medicinal maggots were granted marketing clearance by the FDA in 2004 for treating neuropathic (i.e., diabetic) foot ulcers, pressure ulcers ("bed sores"), venous stasis ulcers, and traumatic and post-surgical wounds failing other forms of conve...

Treating chronic pain, migraine & muscle spasticity through inhibition of neurotransmitter glutamate

... oral prodrug, NGX426, have the potential to treat a number of diseases and disorders. These include migraine and other forms of chronic pain such as neuropathic pain as well as muscle spasticity and rigidity secondary to spinal cord trauma, stroke and multiple sclerosis. ...

Sangamo BioSciences to Present at the Bank of America 2008 Healthcare Conference

... a ZFP Therapeutic for peripheral artery disease. Other therapeutic development programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding pro...

The myth of runner's high revisited with brain imaging

...are also members of the German Research Network of neuropathic Pain (Deutscher Forschungsverbund Neuropathischer ...ition, as a spokesman of the German Association of neuropathic Pain, he feels happy for patients suffering from c... not only of interest to the German Association of neuropathic Pain. 'Now we are very curious about the results o...

Study: diabetic neuropathy costs billions per year in lost work time

... DANVILLE, PA. - Workers who have diabetes with neuropathic symptoms such as numbness or tingling in feet or hands lose the equivalent ...ost was more than twice the amount of lost time of diabetic workers without neuropathic symptoms. For this reason, individuals with diabetes are much more likely t...

neuropathic in Biological Technology

Aegera Initiates Phase 2 Clinical Trial Of AEG33773 - A Small Molecule Targeting Neuropathic Pain

MONTREAL, May 6 /PRNewswire/ - Aegera Therapeutics is pleased to announce the initiation of a Phase 2a, proof-of-concept, clinical trial for AEG33773, a novel, orally bio-available small molecule therapeutic addressing the under-served market of painful diabetic neuropathy. The Phase 2a study, e...

UK's NICE Recommends Spinal Cord Stimulation for Patients with Chronic Neuropathic Pain

Confirms clinical value and cost-effectiveness of spinal cord stimulation NATICK, Mass., Oct. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) today welcomed an announcement by the U.K.'s National Institute for Health and Clinical Excellence (NICE) recommending the use o...

US Neuropathic Pain Market Value Doubles to $5 Billion by 2018

New Indications and Products Offset Patent Expirations SAN FRANCISCO, Sept. 11 /PRNewswire/ -- The U.S. market for drug treatment of major neuropathic pain (NP) conditions is currently valued at $2.6 billion, according to US Neuropathic Pain, a report released today by WWMR, Inc. Grow...

Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain

MONTREAL, March 18 /PRNewswire/ - Aegera Therapeutics announced today the initiation of a Phase 1, first-in-man, clinical trial for AEG33773, a novel, orally bioavailable small molecule in development for the treatment of painful diabetic neuropathy. The Phase I study will evaluate the safety,...

Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain

VALLEY COTTAGE, New York, September 11 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) will hold a conference call today, September 11, 2007, at 8:30 a.m. EDT to discuss the Phase IIb clinical trial of Bicifadine for the treatment of diabetic neuropa...

XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain

Company to Hold a Conference Call Tomorrow (Tuesday) at 8:30 am EDT to Discuss the Clinical Trial Valley Cottage, NEW YORK, September 10 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; TASE: XTL) today announced the initiation of a Phase ...

NeurogesX Reports Second Quarter 2009 Results

...C) approval of Qutenza for treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in co...U-member countries for the treatment of peripheral neuropathic pain in non-diabetic adults, either alone or in co...safety study in on-label indications of peripheral neuropathic pain in non-diabetic adults, either alone or in co...

NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application

...rapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), pain...designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatment of neuropathic pain in non-diabetic adults, either alone or in co...

NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results

...rapies. Its initial focus is on chronic peripheral neuropathic pain, including postherpetic neuralgia (PHN), pain...designed to manage pain associated with peripheral neuropathic pain conditions. Qutenza is currently approved in the European Union for the treatment of neuropathic pain in non-diabetic adults, either alone or in co...

Sangamo BioSciences Reports Second Quarter 2009 Financial Results

... evaluate safety and clinical effect of a ZFP Therapeutic for the treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo has established strategic partnerships with companies in non-therapeutic...

neuropathic in Biological Products

hKvLQT1/hminK-CHO K1 Recombinant Cell Line from Upstate

Description:...and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression. Historically, ion chann...
Company:Upstate

hNav1.6-HEK293 Recombinant Cell Line from Upstate

Description:...and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression. Historically, ion chann...
Company:Upstate

hKv1.5-CHO K1 Recombinant Cell Line from Upstate

Description:...and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression. Historically, ion chann...
Company:Upstate

hHCN4-CHO K1 Recombinant Cell Line from Upstate

Description:...and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression. Historically, ion chann...
Company:Upstate

hERG-CHO K1 Recombinant Cell Line from Upstate

Description:...and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression. Historically, ion chann...
Company:Upstate

hERG-CHO K1 Recombinant Cell Line from Upstate

Description:...and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression. Historically, ion chann...
Company:Upstate

hKv4.2/hKChIP2-CHO K1 Recombinant Cell Line from Upstate

Description:...and consequently have a key function in pain, CNS and the heart. Drugs that modulate ion channels have been investigated in therapeutic areas, such as neuropathic pain, cardiac arrhythmia, hypertension, local anaesthesia, stroke, Parkinson's, obesity, epilepsy, diabetes and depression. Historically, ion chann...
Company:Upstate